These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20536983)

  • 1. Modulation of factor VIII-specific memory B cells.
    Reipert BM; Allacher P; Hausl C; Pordes AG; Ahmad RU; Lang I; Ilas J; Windyga J; Klukowska A; Muchitsch EM; Schwarz HP
    Haemophilia; 2010 May; 16(102):25-34. PubMed ID: 20536983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
    van Helden PM; Van Haren SD; Fijnvandraat K; van den Berg HM; Voorberg J
    Haemophilia; 2010 May; 16(102):35-43. PubMed ID: 20536984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders.
    Hausl C; Ahmad RU; Schwarz HP; Muchitsch EM; Turecek PL; Dorner F; Reipert BM
    Blood; 2004 Jul; 104(1):115-22. PubMed ID: 15001466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe haemophilia A patients have reduced numbers of peripheral memory B cells.
    Irigoyen MB; Felippo ME; Primiani L; Candela M; Bianco RP; De Bracco MM; Galassi N
    Haemophilia; 2012 May; 18(3):437-43. PubMed ID: 21910787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9.
    Allacher P; Baumgartner CK; Pordes AG; Ahmad RU; Schwarz HP; Reipert BM
    Blood; 2011 Jan; 117(1):259-67. PubMed ID: 20889922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro.
    Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A
    Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell memory against factor VIII.
    Reipert BM
    Cell Immunol; 2016 Mar; 301():49-58. PubMed ID: 26780996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies for immune tolerance in haemophilia A.
    Collins PW
    Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
    Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anti-idiotypic antibodies in immune tolerance induction.
    Gilles JG
    Haemophilia; 2010 May; 16(102):80-3. PubMed ID: 20536989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
    Kallas A; Kuuse S; Maimets T; Pooga M
    Thromb Res; 2007; 120(6):911-9. PubMed ID: 17376515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C; Maier E; Schwarz HP; Ahmad RU; Turecek PL; Dorner F; Reipert BM
    Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.
    Hausl C; Ahmad RU; Sasgary M; Doering CB; Lollar P; Richter G; Schwarz HP; Turecek PL; Reipert BM
    Blood; 2005 Nov; 106(10):3415-22. PubMed ID: 16091456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.
    Qian J; Burkly LC; Smith EP; Ferrant JL; Hoyer LW; Scott DW; Haudenschild CC
    Eur J Immunol; 2000 Sep; 30(9):2548-54. PubMed ID: 11009088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
    Hu G; Guo D; Key NS; Conti-Fine BM
    Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.